Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan

NCT03559322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2019-09-23

No results posted yet for this study

Summary

A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Lite Sleep Therapy System in Adults with Obstructive Sleep Apnea

Conditions

  • Obstructive Sleep Apnea of Adult

Interventions

DEVICE

iNAP® Lite Sleep Therapy System

Class II intraoral devices for snoring and/or obstructive sleep apnea

Sponsors & Collaborators

  • Somnics, Inc.

    lead INDUSTRY

Principal Investigators

  • Chung-Chu Chen, Ph.D. · Somnics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-08-01
Completion
2021-12-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03559322 on ClinicalTrials.gov